Amgros 2027 1.709.b

Amgros I/S in Denmark invited bids for “Amgros 2027 1.709.b”. Bids closed on 6 October 2026; the estimated value is DKK 4.25 million. To qualify, bidders need at least one similar completed work.

The work

Supply of various pharmaceutical drugs including Liraglutid and Semaglutid in different forms and strengths to hospital pharmacies

Key facts

Estimated value: DKK 4.25 million
Evaluation: Lowest price (L1) among technically qualified bids
Procedure: Contract notice

What it takes to qualify

Worth a closer look

Obligatorisk udelukkelsesgrund, jf. udbudslovens § 135, stk. 1, nr. 1
Obligatorisk udelukkelsesgrund, jf. udbudslovens § 135, stk. 1, nr. 2
Obligatorisk udelukkelsesgrund, jf. udbudslovens § 135, stk. 1, nr. 3
Obligatorisk udelukkelsesgrund, jf. udbudslovens § 135, stk. 1, nr. 4
Obligatorisk udelukkelsesgrund, jf. udbudslovens § 135, stk. 1, nr. 5
Obligatorisk udelukkelsesgrund, jf. udbudslovens § 135, stk. 1, nr. 6
Obligatorisk udelukkelsesgrund, jf. udbudslovens § 135, stk. 3
Obligatorisk udelukkelsesgrund, jf. udbudslovens § 136, nr. 1
Obligatorisk udelukkelsesgrund, jf. udbudslovens § 136, nr. 2
Obligatorisk udelukkelsesgrund, jf. udbudslovens § 136, nr. 3
Obligatorisk udelukkelsesgrund, jf. udbudslovens § 136, nr. 4

Experience

At least 1 similar work — supply of pharmaceuticals to hospitals

Policy conditions

No reservation, preference or local-content restriction.